Bachir Joseph Sakr

Medical Marijuana Use in Oncology

Gianna Wilkie, Bachir Joseph Sakr, Tina Rizack · JAMA Oncology · 2016 · 95 citations

Addressing clinical trials: Can the Multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program

Lindsay M. Kuroki, Ashley Stuckey, Priya Hirway et al. · Gynecologic Oncology · 2009 · 39 citations · Full text

Nursing, Oncology, Academic Women +13

Effects of adjuvant chemotherapy in HER2-positive or triple-negative pT1ab breast cancers: a multi-institutional retrospective study

Adam J. Olszewski, Yazan Migdady, Susan K. Boolbol et al. · Breast Cancer Research and Treatment · 2013 · 29 citations

Breast Oncology, Oncology, Adjuvant Chemotherapy +5

Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: Application and outcomes

Yazan Migdady, Bachir Joseph Sakr, William M. Sikov et al. · The Breast · 2013 · 18 citations · Full text

Breast Oncology, Oncology, Triple-negative Breast Cancers +9

Neoadjuvant weekly nab-paclitaxel (wA), carboplatin (Cb) plus bevacizumab (B) with or without dose-dense doxorubicin-cyclophosphamide (ddAC) plus B in ER+/HER2-negative (HR+) and triple-negative (TN) breast cancer (BrCa): A BrUOG study.

Natalie Sinclair, Maysa Abu‐Khalaf, Tina Rizack et al. · Journal of Clinical Oncology · 2012 · 12 citations

Breast Oncology, Cancer Management, Pharmacotherapy +17